Oct 10, 2026 · 1 hr 12 min · 23 segments
At nineteen, Elizabeth Holmes dropped out of Stanford University with a promise to revolutionise medicine. Her company, Theranos, claimed it could perform a wide range of medical tests using just a…
In 2003, a 19-year-old student at Stanford University began pursuing an idea she believed could change medicine.
She imagined a future in which patients would no longer need several vials of blood drawn from their arms.
Instead, a tiny sample from a fingerprint could provide doctors with a wide range of information about their health.
People might be able to monitor their health more often, and the fear of needles might no longer keep patients away from essential tests.
It was a remarkable promise, but there was a difference between imagining that future and building the technology to deliver it.
Over the next decade, that difference would become the defining issue in the rise and fall of Theranos.
To understand why so many people believed Elizabeth Holmes, we need to understand the world in which she founded her company.
At the beginning of the 21st century, Silicon Valley was becoming a center of extraordinary wealth and ambition.
Investors were prepared to risk millions on ideas that might transform the way people lived.
The most successful founders were treated as visionaries, not simply businesspeople.
A brilliant young person leaves university, ignores conventional advice, and builds something the experts said could not be done.
She was born in Washington, DC, in February 1984 and spent part of her childhood in Texas.
Holmes later spoke of wanting to make a difference in the world from an early age.
She was academically capable and determined, and in 2002, she enrolled at Stanford University to study chemical engineering.
In 2003, a 19-year-old student at Stanford University began pursuing an idea she believed could change medicine.
She imagined a future in which patients would no longer need several vials of blood drawn from their arms.
Instead, a tiny sample from a fingerprint could provide doctors with a wide range of information about their health.
People might be able to monitor their health more often, and the fear of needles might no longer keep patients away from essential tests.
It was a remarkable promise, but there was a difference between imagining that future and building the technology to deliver it.
Over the next decade, that difference would become the defining issue in the rise and fall of Theranos.
To understand why so many people believed Elizabeth Holmes, we need to understand the world in which she founded her company.
At the beginning of the 21st century, Silicon Valley was becoming a center of extraordinary wealth and ambition.
Investors were prepared to risk millions on ideas that might transform the way people lived.
The most successful founders were treated as visionaries, not simply businesspeople.
A brilliant young person leaves university, ignores conventional advice, and builds something the experts said could not be done.
She was born in Washington, DC, in February 1984 and spent part of her childhood in Texas.
Holmes later spoke of wanting to make a difference in the world from an early age.
She was academically capable and determined, and in 2002, she enrolled at Stanford University to study chemical engineering.
The rest of this transcript — segmented and speaker-labeled, so you land on the exact moment something was said
Search every transcript — by keyword, by phrase, or by meaning, across every show Radar indexes
Trends — what is surging across podcasts, measured against its own baseline
Alerts — when a name you follow appears in a newly indexed episode
No account is needed to search Radar.